News - OxyDial Inc

Dec 26 2023

Artificial intelligence experts share 6 of the biggest AI innovations of 2023: ‘A landmark year’

In the transformative landscape of healthcare, 2023 emerged as a pivotal year for artificial intelligence (AI). With breakthroughs impacting both medical practices and patient experiences, AI became an integral part …

OxyDial

Dec 12 2023

FDA approves cure for sickle cell disease, the first treatment to use gene-editing tool CRISPR

The Food and Drug Administration (FDA) has granted approval for a groundbreaking treatment for sickle cell disease, a debilitating condition affecting over 100,000 Americans, primarily from the Black community. Developed …

OxyDial

Dec 5 2023

AstraZeneca partners with AI company to find cure for cancer

AstraZeneca, the pharmaceutical company renowned for developing one of the COVID-19 vaccines, has entered into a partnership with Absci, a U.S.-based artificial intelligence (AI) biologics firm. The collaboration involves an …

OxyDial

Nov 28 2023

The clinical development of masitinib in sickle cell disease is among the 19 winning projects

AB Science SA has announced that its masitinib in sickle cell disease is among the 19 projects to be funded under the “Hospital-University Research in Health” program. This program, part …

OxyDial

Nov 21 2023

Enhancing Animal Welfare: How AI is Reshaping Diagnosis and Treatment in Animal Health

The global Artificial Intelligence (AI) in Animal Health market, as highlighted in the report released on November 20, 2023, has experienced significant growth, reaching a valuation of USD 901.81 million …

OxyDial

Nov 14 2023

Medical Moment: Doctors near possible breakthrough for sickle cell

Sickle cell disease, affecting over 100,000 Americans, particularly impacts one in 365 African American babies born today. Danielle Lee, diagnosed before birth, endured unimaginable pain due to the genetic blood …

OxyDial

Nov 7 2023

How blockchain, AI can help research into extending human life

Jasmine Smith, the CEO of Rejuve.AI, a Web3-based wellness app, emphasized in an interview with Cointelegraph that decentralized and AI-powered platforms in health research are not designed to replace healthcare …

OxyDial

Oct 31 2023

A landmark gene-editing treatment for sickle cell disease moves closer to reality

The Food and Drug Administration (FDA) is nearing approval of a groundbreaking CRISPR-based therapy for sickle cell disease, marking a historic shift from lab experimentation to clinical application. The FDA, …

OxyDial

Oct 24 2023

ChatGPT, Bard similar in suggesting best method for urologic imaging

A recent study published in Current Problems in Diagnostic Radiology compared the performance of OpenAI’s ChatGPT and Google Bard in suggesting appropriate urologic imaging methods based on American College of …